Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Table: Five-year cost projection by patient type Projections assume 20% price reductions with early biosimilar entry (2029) and 40% reductions with mature competition (2032), consistent with historical biosimilar pricing patterns (Mulcahy et al., RAND 2024)
There are specific differences that affect how they're prescribed, used, and covered by insurance
Vascular dysfunction in Alzheimers disease: a prelude to the pathological process or a consequence of it
Lemley CO et al
These include appetite control, insulin sensitivity, fat oxidation, and overall energy expenditure
US$ 27.52
US$ 26.56
US$ 29.00
US$ 25.41
US$ 20.81
US$ 27.53
US$ 24.73
US$ 24.63
US$ 28.81
